Fig. 2

Effects of different doses of nab-P combined with AP on SKOV-3/DDP. a the nab-P combined with AP’s half inhibition concentration to SKOV-3/DDP (24, 48 and 72 h), b Combined inhibition index, c the Bax, bcl-2, p-VEGFR-2 and MMP-2 protein expression of different groups by Western blot (WB), d the Bax, bcl-2, p-VEGFR-2 and MMP-2 protein expression of different groups by Immunofluorescence (IF), e the invasion in different groups by Transwell assay, f the migration in different groups by Wound healing assay. Note: *P < 0.05, **P < 0.01, medication group vs control group, △P < 0.05, △△P < 0.01, comparison of two sets of data